Patents by Inventor Satoshi Shuto

Satoshi Shuto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11944908
    Abstract: An object is to provide a user with motivation to enjoy waking up in the morning and guide the user to sufficient awakening by generating a breeding event in a breeding game of a virtual life form when the user wakes up in the morning. A game server that manages progress of a breeding game of a virtual life form can provide a user with motivation to enjoy waking up in the morning and guide the user to sufficient awakening by generating a breeding event in a breeding game of a virtual life form when the user wakes up in the morning. The game server includes circuitry configured to acquire a wake-up time of a user; and a update the breeding game in accordance with the acquired wake-up time.
    Type: Grant
    Filed: November 18, 2022
    Date of Patent: April 2, 2024
    Assignee: THE POKEMON COMPANY
    Inventors: Takayuki Shindo, Satoshi Ogawa, Kaname Kosugi, Marie Shuto, Koya Nakahata
  • Publication number: 20230099067
    Abstract: The present invention provides a compound represented by General Formula (1) or (1?) [in the formula, R1 and R2 each independently represents a hydrogen atom or a hydroxy group; R3 represents an alkyl group having 1 to 6 carbon atoms; R4 represents a halogen atom or an alkyl group; m indicates the number of R4 and represents an integer of 0 to 4; in a case where m is 2 or more, a plurality of R4's may be the same or different from each other; n represents an integer of 1 to 6; and n? represents an integer of 1 to 4] and a neutrophil infiltration suppressor containing the compound as an active ingredient.
    Type: Application
    Filed: February 18, 2021
    Publication date: March 30, 2023
    Inventors: Satoshi SHUTO, Tadashi MATSUDA, Ryuta MUROMOTO, Hayato FUKUDA
  • Patent number: 10287260
    Abstract: Provided is a material that, when compared with SAPd, exhibits the similar activity in cross-coupling (CC) reactions, can decrease the amount of catalytic metal that is mixed into the reaction product, and increases the number of times use can be repeated. Provided are a catalyst and a catalyst precursor that use a catalytic metal other than Pd and that exhibit the CC reaction activity similar to when Pd is used. Provided are a catalyst and a catalyst precursor that exhibit the similar CC reaction activity when using Pd or a catalytic metal other than Pd, without using a carrier such as metal and without using piranha solution. A composite wherein catalytic metal nanoparticles are dispersed in a continuous phase comprising a polymer having C2-6 alkylene group units and phenylene group units (an alkylene group unit being bonded to at least the first and fourth position of the phenylene group unit). The particle diameter of the catalytic metal nanoparticles is at most 20 nm.
    Type: Grant
    Filed: March 28, 2014
    Date of Patent: May 14, 2019
    Assignees: Japan Science and Technology Agency, Furuya Metal Co., Ltd.
    Inventors: Mitsuhiro Arisawa, Satoshi Shuto, Naoyuki Hoshiya, Satoshi Arai
  • Publication number: 20160152583
    Abstract: Provided is a material that, when compared with SAPd, exhibits the similar activity in cross-coupling (CC) reactions, can decrease the amount of catalytic metal that is mixed into the reaction product, and increases the number of times use can be repeated. Provided are a catalyst and a catalyst precursor that use a catalytic metal other than Pd and that exhibit the CC reaction activity similar to when Pd is used. Provided are a catalyst and a catalyst precursor that exhibit the similar CC reaction activity when using Pd or a catalytic metal other than Pd, without using a carrier such as metal and without using piranha solution. A composite wherein catalytic metal nanoparticles are dispersed in a continuous phase comprising a polymer having C2-6 alkylene group units and phenylene group units (an alkylene group unit being bonded to at least the first and fourth position of the phenylene group unit). The particle diameter of the catalytic metal nanoparticles is at most 20 nm.
    Type: Application
    Filed: March 28, 2014
    Publication date: June 2, 2016
    Inventors: Mitsuhiro ARISAWA, Satoshi SHUTO, Naoyuki HOSHIYA, Satoshi ARAI
  • Patent number: 9175004
    Abstract: The present invention provides the catalyst precursor that has excellent safety and stability, has high stable activity retention rate, can be recycled, increases yield resulted from a reaction, and is easily processed into various forms. The catalyst precursor comprises a structure in which the entire structure is composed of gold or a gold-based alloy and the surface of the structure is modified with elemental sulfur, or at least the surface of the structure is composed of gold or a gold-based alloy and the surface of the structure is modified with elemental sulfur, and a catalytic metal compound supported on the structure, wherein the catalyst precursor has peaks derived from the catalytic metal compound and also sulfur as analyzed by photoelectron spectroscopy, and wherein the peak derived from sulfur is of the sulfur 1s orbital observed within a range of 2470 eV±2 eV in terms of the peak top position.
    Type: Grant
    Filed: July 16, 2010
    Date of Patent: November 3, 2015
    Assignees: NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY, FURUYA METAL CO., LTD.
    Inventors: Mitsuhiro Arisawa, Satoshi Shuto, Naoyuki Hoshiya
  • Publication number: 20120115714
    Abstract: The present invention provides the catalyst precursor that has excellent safety and stability, has high stable activity retention rate, can be recycled, increases yield resulted from a reaction, and is easily processed into various forms. The catalyst precursor comprises a structure in which the entire structure is composed of gold or a gold-based alloy and the surface of the structure is modified with elemental sulfur, or at least the surface of the structure is composed of gold or a gold-based alloy and the surface of the structure is modified with elemental sulfur, and a catalytic metal compound supported on the structure, wherein the catalyst precursor has peaks derived from the catalytic metal compound and also sulfur as analyzed by photoelectron spectroscopy, and wherein the peak derived from sulfur is of the sulfur 1s orbital observed within a range of 2470 eV±2 eV in terms of the peak top position.
    Type: Application
    Filed: July 16, 2010
    Publication date: May 10, 2012
    Applicant: FURUYA METAL CO., LTD.
    Inventors: Mitsuhiro Arisawa, Satoshi Shuto, Naoyuki Hoshiya
  • Patent number: 5621142
    Abstract: Disclosed are a novel optically active compound represented by formula (1), a racemic modification thereof, and a pharmaceutically acceptable acid addition salt of the optically active compound or racemic modification thereof: ##STR1## wherein R is a straight chain or branched C.sub.1 -C.sub.5 aliphatic group which is saturated or unsaturated, or a phenyl group which is unsubstituted or substituted with 1 to 3 substituents which are each independently selected from the group consisting of a halogen atom, a C.sub.1 -C.sub.4 alkyl group, a nitro group, an amino group, a hydroxyl group and a C.sub.1 -C.sub.4 alkoxy group; and mark * indicates an asymmetric carbon atom.
    Type: Grant
    Filed: July 30, 1996
    Date of Patent: April 15, 1997
    Assignee: Asahi Kasei Kogyo Kabushiki Kaisha
    Inventors: Daisuke Mochizuki, Satoshi Shuto
  • Patent number: 5200515
    Abstract: Compounds of the formula ##STR1## wherein R.sub.1 and R.sub.2 are each C.sub.16-18 long-chain aliphatic acyl and are the same or different; and pharmacologically acceptable salts thereof are disclosed. These novel compounds are effective against 5-FU-resistant tumor cells, have low toxicity, and are not inactivated by nucleoside phosphorylase in vivo.
    Type: Grant
    Filed: May 16, 1991
    Date of Patent: April 6, 1993
    Assignee: Asahi Kasei Kogyo Kabushiki Kaisha
    Inventors: Satoshi Shuto, Hiromichi Itoh, Takumi Obara, Tatsuro Fujiwara
  • Patent number: 5187174
    Abstract: A compound of the formula ##STR1## wherein A is adenine-9-yl and X is halogen, Preferably iodine, or a pharmaceutically acceptable salt thereof. It is a novel derivative of neplanocin A and has almost the same level of cytotoxic activity. However, it is not inactivated by the action of adenosine deaminase. It is produced by replacing a hydroxyl at position-6' in neplanocin A or 2', 3'-O-protected neplanocin A with halogen by use of a halogenating agent, and when hydroxyl at position-2' or -3' is protected, removing the protective group thereof.
    Type: Grant
    Filed: March 18, 1991
    Date of Patent: February 16, 1993
    Assignee: Asahi Kasei Kogyo Kabushiki Kaisha
    Inventors: Satoshi Shuto, Takumi Obara, Hiromichi Itoh, Takehiro Koshio, Tatsuro Fujiwara, Masao Yaso
  • Patent number: 5051499
    Abstract: Novel nucleoside-phospholipid conjugates of the formula ##STR1## wherein R.sub.1 is C.sub.14-24 long chain aliphatic acyl or C.sub.1-24 aliphatic alkyl, R.sub.2 is C.sub.2-10 aliphatic acyl or C.sub.1-24 aliphatic alkyl and N.sub.s is a nucleoside residue; and pharmacologically acceptable salts thereof are prepared in a one-step reaction by reacting the corresponding nucleoside and glycerophospholipid derivative in the presence of phospholipase D-P.
    Type: Grant
    Filed: November 28, 1989
    Date of Patent: September 24, 1991
    Assignee: Toyo Jozo Kabushiki Kaisha
    Inventors: Satoshi Shuto, Hiromichi Itoh, Kiyofumi Fukukawa, Masatoshi Tsujino
  • Patent number: 4921951
    Abstract: Novel nucleoside-phospholipid conjugates of the formula ##STR1## wherein R.sub.1 is C.sub.14-24 long chain aliphatic acyl or C.sub.1-24 aliphatic alkyl and N.sub.s is a nucleoside residue; and pharmacologically acceptable salts thereof are prepared in a one-step reaction by reacting the corresponding nucleoside and glycerophospholipid derivative in the presence of phospholipase D-P.
    Type: Grant
    Filed: September 28, 1987
    Date of Patent: May 1, 1990
    Assignee: Toyo Jozo Kabushiki Kaisha
    Inventors: Satoshi Shuto, Hiromichi Itoh, Kiyofumi Fukukawa, Masatoshi Tsujino
  • Patent number: 4797479
    Abstract: A compound of the formula ##STR1## wherein R.sub.1 and R.sub.2 are long-chain fatty acid residue, and Ns is nucleoside residue selected from the group consisting of 5-fluorouridine-5'-yl, 5-fluoro-2'-deoxyuridine-5'-yl-, bredinin-5'-yl, tubercidine-5'-yl-, neplanocin A-6'-yl-, 5-fluorocytidine-5'-yl-, arabinosylcytosine-5'-yl, arabinocyl-5-fluorocytosine-5'-yl-, arabinosyladenine-5'-yl- and arabinosylthymine-5 '-yl-, and pharmacologically acceptable salts thereof, having antitumor activity.
    Type: Grant
    Filed: April 15, 1986
    Date of Patent: January 10, 1989
    Assignee: Toyo Jozo Kabushiki Kaisha
    Inventors: Satoshi Shuto, Hiromichi Ito, Kiyofumi Fukukawa, Hideo Sakakibara, Masatoshi Tsujino